Mr Abdalla Ali

PhD Student
Department of Microbiology and Immunology
University of Melbourne

Research Activities

One approach toward eliminating HIV latency is the activation of HIV viral production by latency reversal agents (LRAs) to induce virus mediated cytolysis or clearance through immune recognition (often called “shock and kill”). However, currently available LRAs are not specific for HIV, have off target effects and lack sufficient potency to eliminate infected T- cells. Nanoparticle delivery systems possess several advantages over more traditional drug delivery methods, and could potentially increase potency and reduce toxicity. However, there are challenges for uptake of nanoparticles in non-phagocytic resting T‐cells, the major reservoir of latent HIV.


Cell culture, flow cytometry, confocal microscopy, nanoparticles fabrication, PCR

Disease Models

HIV latency

Upcoming Events

  • Jun 20

    ASM Microbe 2019

    Moscone Center 747 Howard St. San Francisco, CA 94103 MORE INFO
  • Jun 27

    4th Asia-Pacific AIDS & Co-Infections Conference

  • Jun 30

    Annual Meeting of the Australian Society for Microbiology 2019

    Adelaide Convention Centre MORE INFO